Securities Code: 002432 Securities Abbreviation: Anji Medical Announcement No.: 2026-016 Tianjin Anji Medical Electronic Co., Ltd. Announcement on the Company's 2025 Profit Distribution Plan The Company and the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from false records, misleading statements, or material omissions.
I. Deliberation Procedures Tianjin Anji Medical Electronic Co., Ltd. (hereinafter referred to as the "Company") held the Fourth Meeting of the Seventh Board of Directors on April 28, 2026, and deliberated and approved the Company's "Proposal on the 2025 Profit Distribution Plan." This proposal needs to be submitted to the Company's 2025 Annual General Meeting for deliberation.
II. Company's 2025 Profit Distribution Plan
-
Company's Distributable Profit Audited by Rongcheng Certified Public Accountants (Special General Partnership), the Company's net profit attributable to shareholders of the listed company in 2025 was RMB 2,266,748,271.38, and the parent company's net profit in 2025 was RMB 729,066,536.72. According to the "Company Law" and the "Articles of Association," the statutory surplus reserve of RMB 38,226,762.71 was appropriated. As of December 31, 2025, the undistributed profit at the end of the consolidated financial statements was RMB 20,294,426,420.35, and the undistributed profit at the end of the parent company's financial statements was RMB 696,885,431.51.
-
Profit Distribution Plan According to Rule 5.3.2 of the "Shenzhen Stock Exchange Stock Listing Rules," when a listed company formulates a profit distribution plan, it shall be based on the distributable profit in the parent company's financial statements. At the same time, to avoid over-distribution, the Company shall determine the specific profit distribution ratio based on the lower of the distributable profit in the consolidated financial statements and the parent company's financial statements.